Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 2,000 shares at $295.50 ($591K) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Open-market sale of $591k UTHR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |